AGREEMENTBaker Julian • August 15th, 2006 • Biological products, (no disgnostic substances)
Company FiledAugust 15th, 2006 IndustryIn accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement on Schedule 13D relating to the Common Stock, $0.001 par value, of Seattle Genetics, Inc. is being filed with the Securities and Exchange Commission on behalf of each of them.